155 related articles for article (PubMed ID: 30637990)
1. Bisubstrate inhibitors to target histone acetyltransferase 1.
Ngo L; Brown T; Zheng YG
Chem Biol Drug Des; 2019 May; 93(5):865-873. PubMed ID: 30637990
[TBL] [Abstract][Full Text] [Related]
2. 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.
Ghizzoni M; Wu J; Gao T; Haisma HJ; Dekker FJ; George Zheng Y
Eur J Med Chem; 2012 Jan; 47(1):337-44. PubMed ID: 22100137
[TBL] [Abstract][Full Text] [Related]
3. Rational design of substrate-based multivalent inhibitors of the histone acetyltransferase Tip60.
Yang C; Ngo L; Zheng YG
ChemMedChem; 2014 Mar; 9(3):537-41. PubMed ID: 24446345
[TBL] [Abstract][Full Text] [Related]
4. Histone acetyltransferases: challenges in targeting bi-substrate enzymes.
Wapenaar H; Dekker FJ
Clin Epigenetics; 2016; 8():59. PubMed ID: 27231488
[TBL] [Abstract][Full Text] [Related]
5. Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60.
Wu J; Xie N; Wu Z; Zhang Y; Zheng YG
Bioorg Med Chem; 2009 Feb; 17(3):1381-6. PubMed ID: 19114310
[TBL] [Abstract][Full Text] [Related]
6. Recent insights into
Poziello A; Nebbioso A; Stunnenberg HG; Martens JHA; Carafa V; Altucci L
Epigenetics; 2021 Aug; 16(8):838-850. PubMed ID: 33016232
[TBL] [Abstract][Full Text] [Related]
7. Structure of the histone acetyltransferase Hat1: a paradigm for the GCN5-related N-acetyltransferase superfamily.
Dutnall RN; Tafrov ST; Sternglanz R; Ramakrishnan V
Cell; 1998 Aug; 94(4):427-38. PubMed ID: 9727486
[TBL] [Abstract][Full Text] [Related]
8. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
[TBL] [Abstract][Full Text] [Related]
9. Understanding HAT1: A Comprehensive Review of Noncanonical Roles and Connection with Disease.
Ortega MA; De Leon-Oliva D; Garcia-Montero C; Fraile-Martinez O; Boaru DL; Del Val Toledo Lobo M; García-Tuñón I; Royuela M; García-Honduvilla N; Bujan J; Guijarro LG; Alvarez-Mon M; Alvarez-Mon MÁ
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107673
[TBL] [Abstract][Full Text] [Related]
10. Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
Wapenaar H; van der Wouden PE; Groves MR; Rotili D; Mai A; Dekker FJ
Eur J Med Chem; 2015 Nov; 105():289-96. PubMed ID: 26505788
[TBL] [Abstract][Full Text] [Related]
11. The relevance of K
Wapenaar H; van den Bosch T; Leus NGJ; van der Wouden PE; Eleftheriadis N; Hermans J; Hailu GS; Rotili D; Mai A; Dömling A; Bischoff R; Haisma HJ; Dekker FJ
Eur J Med Chem; 2017 Aug; 136():480-486. PubMed ID: 28527406
[TBL] [Abstract][Full Text] [Related]
12. Identification of a gene encoding a yeast histone H4 acetyltransferase.
Kleff S; Andrulis ED; Anderson CW; Sternglanz R
J Biol Chem; 1995 Oct; 270(42):24674-7. PubMed ID: 7559580
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer using KAT inhibitors to mimic lethal knockouts.
Brown JA; Bourke E; Eriksson LA; Kerin MJ
Biochem Soc Trans; 2016 Aug; 44(4):979-86. PubMed ID: 27528742
[TBL] [Abstract][Full Text] [Related]
14. Human histone acetyltransferase 1 (Hat1) acetylates lysine 5 of histone H2A in vivo.
Tafrova JI; Tafrov ST
Mol Cell Biochem; 2014 Jul; 392(1-2):259-72. PubMed ID: 24682716
[TBL] [Abstract][Full Text] [Related]
15. Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.
Deng Y; Deng S; Ho YH; Gardner SM; Huang Z; Marmorstein R; Huang R
J Med Chem; 2021 Jun; 64(12):8263-8271. PubMed ID: 34110812
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel inhibitors of histone acetyltransferases.
Eliseeva ED; Valkov V; Jung M; Jung MO
Mol Cancer Ther; 2007 Sep; 6(9):2391-8. PubMed ID: 17876038
[TBL] [Abstract][Full Text] [Related]
17. p300/CBP-associated factor histone acetyltransferase processing of a peptide substrate. Kinetic analysis of the catalytic mechanism.
Lau OD; Courtney AD; Vassilev A; Marzilli LA; Cotter RJ; Nakatani Y; Cole PA
J Biol Chem; 2000 Jul; 275(29):21953-9. PubMed ID: 10777508
[TBL] [Abstract][Full Text] [Related]
18. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
19. The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3-H4 substrate.
Han J; Lachance C; Ricketts MD; McCullough CE; Gerace M; Black BE; Côté J; Marmorstein R
J Biol Chem; 2018 Mar; 293(12):4498-4509. PubMed ID: 29382722
[TBL] [Abstract][Full Text] [Related]
20. Histone Acetyltransferase-Dependent Pathways Mediate Upregulation of NADPH Oxidase 5 in Human Macrophages under Inflammatory Conditions: A Potential Mechanism of Reactive Oxygen Species Overproduction in Atherosclerosis.
Vlad ML; Manea SA; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
Oxid Med Cell Longev; 2019; 2019():3201062. PubMed ID: 31565149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
